Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury
Authors:
- Chris J. ScottonCSChris J. Scotton
- Malvina A. KrupiczojcMKMalvina A. Krupiczojc
- Melanie KönigshoffMKMelanie Königshoff
- Paul F. MercerPMPaul F. Mercer
- Y.C. Gary LeeYLY.C. Gary Lee
- Naftali KaminskiNKNaftali Kaminski
- John MorserJMJohn Morser
- Joseph M. PostJPJoseph M. Post
- Toby M. MaherTMToby M. Maher
- Andrew G. NicholsonANAndrew G. Nicholson
- James D. MoffattJMJames D. Moffatt
- Geoffrey J. LaurentGLGeoffrey J. Laurent
Open Access
- 3 August 2009
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 119 (9) , 2550-2563
Abstract
Uncontrolled activation of the coagulation cascade contributes to the pathophysiology of several conditions, including acute and chronic lung diseases. Coagulation zymogens are considered to be largely derived from the circulation and locally activated in response to tissue injury and microvascular leak. Here we report that expression of coagulation factor X (FX) is locally increased in human and murine fibrotic lung tissue, with marked immunostaining associated with bronchial and alveolar epithelia. FXa was a potent inducer of the myofibroblast differentiation program in cultured primary human adult lung fibroblasts via TGF-β activation that was mediated by proteinase-activated receptor–1 (PAR1) and integrin αvβ5. PAR1, αvβ5, and α-SMA colocalized to fibrotic foci in lung biopsy specimens from individuals with idiopathic pulmonary fibrosis. Moreover, we demonstrated a causal link between FXa and fibrosis development by showing that a direct FXa inhibitor attenuated bleomycin-induced pulmonary fibrosis in mice. These data support what we believe to be a novel pathogenetic mechanism by which FXa, a central proteinase of the coagulation cascade, is locally expressed and drives the fibrotic response to lung injury. These findings herald a shift in our understanding of the origins of excessive procoagulant activity and place PAR1 central to the cross-talk between local procoagulant signaling and tissue remodeling.Keywords
This publication has 69 references indexed in Scilit:
- Role of Protease Activated Receptor 2 in Experimental Acute Lung Injury and Lung FibrosisThe Anatomical Record, 2009
- Thrombin Induces Fibroblast CCL2/JE Production and Release via Coupling of PAR1to Gαqand Cooperation between ERK1/2 and Rho Kinase Signaling PathwaysMolecular Biology of the Cell, 2008
- Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?British Journal of Pharmacology, 2008
- Factor Xa Stimulates Proinflammatory and Profibrotic Responses in Fibroblasts via Protease-Activated Receptor-2 ActivationThe American Journal of Pathology, 2008
- Tissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitisJournal of Experimental Medicine, 2007
- Ligation of protease-activated receptor 1 enhances v 6 integrin-dependent TGF- activation and promotes acute lung injuryJournal of Clinical Investigation, 2006
- OROPHARYNGEAL ASPIRATION OF A SILICA SUSPENSION PRODUCES A SUPERIOR MODEL OF SILICOSIS IN THE MOUSE WHEN COMPARED TO INTRATRACHEAL INSTILLATIONExperimental Lung Research, 2006
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- Molecular Monitoring of Bleomycin-Induced Pulmonary Fibrosis by cDNA Microarray-Based Gene Expression ProfilingBiochemical and Biophysical Research Communications, 2001
- Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary FibrosisThe American Journal of Pathology, 2001